IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 1 biotech developing vaccines for respiratory diseases.
Industry: Health Care
Latest Trade: $9.77 0.00 (0.0%)
First Day Return: +133.1%
Return from IPO: -34.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/07/2021 |
Offer Price | $15.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 12.1 |
Deal Size ($mm) | $182 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/28/2021 |
Offer Price | $15.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 12.1 |
Deal Size ($mm) | $182 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Jefferies |
TD Cowen |
more |
Company Data | |
---|---|
Headquarters | Seattle, WA, United States |
Founded | 2017 |
Employees | 22 |
Website www.icosavax.com |